¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£¾ÏÇÐȸ ILCA School of Liver Cancer : 2024-04-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑ°£¾ÏÇÐȸ ILCA School of Liver Cancer : 2024-04-06
±³À°ÀÏÀÚ : 2024-04-06
±³À°Àå¼Ò : ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀǽÇ

±³À°ÁÖÁ¦ : ILCA School of Liver Cancer

ÁÖÃÖ±â°ü : ´ëÇÑ°£¾ÏÇÐȸ
´ã´çÀÚ : ¿ÀÀ±Àç ´ë¸®
¿¬¶ôó : 02-373-1005  

À̸ÞÀÏ : klca@hbni.co.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú

Âü¼®¿¹»óÀÎ : 70¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 300,000¿ø  

ºñ°í ILCA member 200,000¿ø / Non member 300,000¿ø / Resident, Fellow, Trainee, Researcher 70,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 08:40~08:55 Exploring Tumor Microenvironment and Immunology in HCC Pil Soo Sung(The Catholic Univ. of Korea)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 08:55~09:10 The Oncogenomic Landscape in HCC Sun Young Yim(Korea Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 09:10~09:25 Pathological and Molecular Features of HCC and CCC Haeryoung Kim (Seoul National Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 09:25~09:40 Molecular Features and Classification of ICC and Combined HCC-CCC Hyun Goo Woo (Ajou Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 09:40~10:00 Meet the Professor and Speaker (Discussion with Q&A) Jessica Zucman-Rossi, Joong-Won Park, Young Nyun Park, Moon Seok Choi(Univ. Paris Descartes, France, Myongji Hospital, Hanyang Univ. , Yonsei Univ., Sungkyunkwan Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 10:00~10:15 What is the Best Option for Advanced HCC?: Second-Line and Sequential Therapy  Bo Hyun Kim(National Cancer Center)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 10:15~10:30 Can We Predict Treatment Response in the Era of Immuno-Oncology? Do Young Kim (Yonsei Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 10:30~10:45 How to Expect and Manage the Adverse Events of Immunotherapy? Wonseok Kang (Sungkyunkwan Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 10:45~11:00 How to Boost TKI Efficacy in Advanced HCC with Combination Therapies Ju Hyun Shim (Univ. of Ulsan)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 11:00~11:20 Meet the Professor and Speaker (Discussion with Q&A) Tim Meyer, Jong Young Choi, Lorenza Rimassa, Ho Yeong Lim(Univ. College London, UK, The Catholic Univ. of Korea, Humanitas Univ., Italy,  Sungkyunkwan Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 11:40~11:55 What are the Current and Future Trends in Imaging Diagnosis of HCC? So Yeon Kim(Univ. of Ulsan)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 11:55~12:10 Imaging-Based Prediction of Prognosis for HCC Seung Baek Hong (Pusan National Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 12:10~12:25 Surveillance and Post-Treatment Response Evaluation Eun Sun Jang (Seoul National Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 12:25~12:40 Optimal Medical Care to Improve Outcomes after HCC Treatment Sung Won Lee (The Catholic Univ. of Korea)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 13:40~13:55 Evolving Role of TACE in the Intermediate-Stage HCC: Good or Poor Responders? Dongho Hyun(Sungkyunkwan Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 13:55~14:10 Transarterial Radioembolization for HCC: Patient Selection and Assessment Hyo-Cheol Kim (Seoul National Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 14:10~14:25 Evolution of Radiotherapy for HCC: Balancing Tumor Control and Hepatic Function Preservation Sang Min Yoon(Univ. of Ulsan)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 14:25~14:40 Particle Beam Radiotherapy: Best Indications for HCC Tae Hyun Kim(National Cancer Center)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 14:40~14:55 Minimally Invasive Liver Resection for HCC and CCC Dong-Sik Kim(Korea Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 14:55~15:10 Liver Transplantation in HCC and CCC: Expanding Indications Dong Jin Joo (Yonsei Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 15:10~15:25 Clinical Decision in Borderline Lesions for Local Ablation Therapy Dong Ho Lee (Seoul National Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 15:25~15:40 Role of Local Ablation Therapy as a Bridge for Curative Therapy Joon-Il Choi (The Catholic Univ. of Korea)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 16:00~16:20 HCC with Intermediate Stage Jung Hee Kim (Hallym Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 16:20~16:40 HCC with Vascular Invasion Young-Sun Lee (Korea Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 16:40~17:00 HCC with Metastasis Sangyoun Hwang(Dongnam Inst. of Radiological £¦ Medical Sciences)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£¾ÏÇÐȸ ILCA School of Liver Cancer : 2024-04-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦ 37Â÷ º½ Çмú´ëȸ(2ÀÏÂ÷) : 2024-04-06
´ÙÀ½±Û ÇѾç´ëÇб³º´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-04-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 5 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 9 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 5 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 7 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 6 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 12 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 6 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 2 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 6 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 4 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 7 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 3 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 9 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 3 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 6 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷